{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:23:27Z","timestamp":1791152607996,"version":"4.1.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.pharma.2009.06.001","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T09:14:23Z","timestamp":1249290863000},"page":"365-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["La substitution aux opiac\u00e9s\u00a0: le point de vue des usagers"],"prefix":"10.1016","volume":"67","author":[{"given":"P.","family":"Chappard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7396","key":"10.1016\/j.pharma.2009.06.001_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow-up study","volume":"326","author":"Strang","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pharma.2009.06.001_bib2","doi-asserted-by":"crossref","unstructured":"Commentaire d\u2019Andrew Byrne sur l\u2019\u00e9tude\u00a0: Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow-up study. BMJ 2003; 326(7396):959\u201360.","DOI":"10.1136\/bmj.326.7396.959"},{"key":"10.1016\/j.pharma.2009.06.001_bib3","unstructured":"Emmanuelli J. Tendances en mati\u00e8re de r\u00e9duction des risques chez les usagers de drogues par voie IV, InVS, 2001."},{"key":"10.1016\/j.pharma.2009.06.001_bib4","unstructured":"Conf\u00e9rence de consensus\u00a0: strat\u00e9gies th\u00e9rapeutiques pour les personnes d\u00e9pendantes des opiac\u00e9s: place des traitements de substitution (23 et 24 juin 2004\u00a0\u2013\u00a0Lyon)."},{"issue":"12","key":"10.1016\/j.pharma.2009.06.001_bib5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.socscimed.2007.02.049","article-title":"Buprenorphine substitution treatment in France: drug users\u2019 views of the doctor\u2013user relationship","volume":"64","author":"Guichard","year":"2007","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.pharma.2009.06.001_bib6","series-title":"Les conduites addictives","author":"Morel","year":"2008"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345090900087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000345090900087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:27:27Z","timestamp":1757719647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000345090900087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S000345090900087X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2009.06.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La substitution aux opiac\u00e9s\u00a0: le point de vue des usagers","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2009.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}